Sale of 10,434 shares at $107.1402 per share.
Reporting Person Quinlan Paul T · Officer Title General Counsel · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0000907654-26-000077 · filed 2026-08-14 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-08-14. https://desqlong.com/cards/0000907654-26-000077-4 (retrieved 2026-09-26).